Secretary for Health Prof Lo Chung-mau met a delegation led by Guangdong Provincial Medical Products Administration (GDMPA) General Director Jiang Xiaodong today, with both sides agreeing to further deepen collaboration in relevant areas. Prof Lo said the Hong Kong Special Administrative Region Government expressed its sincere gratitude to the GDMPA for its staunch support for Hong Kong in the past, including the implementation of the initiatives of, among others, the measure of using Hong Kong registered drugs and medical devices used in Hong Kong public hospitals in the Guangdong-Hong Kong-Macao Greater Bay Area and streamlining of the approval procedures for Hong Kong registered traditional proprietary Chinese medicines (pCms) for external use to be registered and sold in the Mainland. The Government and the GDMPA agreed at the meeting to further deepen collaboration on the regulation of Chinese medicines (CM), the formulation of Greater Bay Area Chinese medicine standards,
The Government welcomed an announcement by Guangdong on the recruitment of Hong Kong Chinese medicine practitioners (CMPs) by public healthcare institutions in the Mainland cities of the Guangdong-Hong Kong-Macao Greater Bay Area.
The Traditional Chinese Medicine Bureau of Guangdong Province today announced that Hong Kong CMPs will be recruited within 2021, on contract terms, by selected pilot sites of public Chinese medicine healthcare institutions in Guangzhou and Shenzhen.
The recruitment procedures, as well as terms and conditions of employment, will be determined by the relevant healthcare institutions. The authorities will take into account the implementation situation when considering whether the scope of the pilot sites should be expanded.
Secretary for Food & Health Prof Sophia Chan said the Hong Kong Special Administrative Region Government welcomes the measure and expressed gratitude to the relevant authorities of the central government and the province for their staunch support to the development of Chinese medicine in Hong Kong.
“The measure enables Hong Kong CMPs to further their practice within the national healthcare system, thereby promoting exchanges in Chinese medicine and providing Hong Kong CMPs, in particular the younger generation, with the opportunity to pursue development in the bay area."
Under Hong Kong’s Closer Economic Partnership Arrangement with the Mainland and relevant supplementary agreements, a series of policies has been in place to enable Hong Kong CMPs to practise Chinese medicine and establish healthcare institutions in the Mainland, Prof Chan added.
“The latest arrangement allows Hong Kong CMPs to practise in Mainland public healthcare institutions, thereby expanding their scope for development.”
http://dlvr.it/S6bGzc
http://dlvr.it/S6bGzc